Please fill the following form to contact us.
We welcome discussions on strategic collaborations with companies that share our ambition to advance novel therapies for patients.
Partnerships are and continue to be accelerators for our research and development pipeline, providing us with access to innovation, indication expertise and non-dilutive capital as well as the ability to expand our reach into areas beyond our core focus.